165 related articles for article (PubMed ID: 37367670)
1. Holothurin A Inhibits RUNX1-Enhanced EMT in Metastasis Prostate Cancer via the Akt/JNK and P38 MAPK Signaling Pathway.
Janta S; Pranweerapaiboon K; Vivithanaporn P; Plubrukarn A; Chairoungdua A; Prasertsuksri P; Apisawetakan S; Chaithirayanon K
Mar Drugs; 2023 Jun; 21(6):. PubMed ID: 37367670
[TBL] [Abstract][Full Text] [Related]
2. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of Snail through AKT/GSK-3β signaling pathway is required for TNF-α-induced epithelial-mesenchymal transition in prostate cancer PC3 cells.
Wang H; Fang R; Wang XF; Zhang F; Chen DY; Zhou B; Wang HS; Cai SH; Du J
Eur J Pharmacol; 2013 Aug; 714(1-3):48-55. PubMed ID: 23769744
[TBL] [Abstract][Full Text] [Related]
4. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
Zhang H; Sun JD; Yan LJ; Zhao XP
Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
[TBL] [Abstract][Full Text] [Related]
5. HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling Pathway.
Lv DJ; Song XL; Huang B; Yu YZ; Shu FP; Wang C; Chen H; Zhang HB; Zhao SC
Theranostics; 2019; 9(18):5166-5182. PubMed ID: 31410208
[No Abstract] [Full Text] [Related]
6. Suppression of cathepsin a inhibits growth, migration, and invasion by inhibiting the p38 MAPK signaling pathway in prostate cancer.
Park S; Kwon W; Park JK; Baek SM; Lee SW; Cho GJ; Ha YS; Lee JN; Kwon TG; Kim MO; Ryoo ZY; Han SH; Han JE; Choi SK
Arch Biochem Biophys; 2020 Jul; 688():108407. PubMed ID: 32407712
[TBL] [Abstract][Full Text] [Related]
7. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer.
Li Q; Lai Q; He C; Fang Y; Yan Q; Zhang Y; Wang X; Gu C; Wang Y; Ye L; Han L; Lin X; Chen J; Cai J; Li A; Liu S
J Exp Clin Cancer Res; 2019 Aug; 38(1):334. PubMed ID: 31370857
[TBL] [Abstract][Full Text] [Related]
8. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
9. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract][Full Text] [Related]
10. IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9.
Huang Q; Lan F; Wang X; Yu Y; Ouyang X; Zheng F; Han J; Lin Y; Xie Y; Xie F; Liu W; Yang X; Wang H; Dong L; Wang L; Tan J
Mol Cancer; 2014 Jan; 13():18. PubMed ID: 24479681
[TBL] [Abstract][Full Text] [Related]
11. AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells.
Liu ZC; Wang HS; Zhang G; Liu H; Chen XH; Zhang F; Chen DY; Cai SH; Du J
Biochim Biophys Acta; 2014 Oct; 1840(10):3096-105. PubMed ID: 25088797
[TBL] [Abstract][Full Text] [Related]
12. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
13. The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer.
Tian J; Zhang H; Mu L; Wang M; Li X; Zhang X; Xie E; Ma M; Wu D; Du Y
Exp Cell Res; 2020 Sep; 394(1):112128. PubMed ID: 32522441
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
15. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract][Full Text] [Related]
16. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.
Yang MH; Jung SH; Um JY; Kumar AP; Sethi G; Ahn KS
Life Sci; 2022 Apr; 295():120395. PubMed ID: 35181309
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
[TBL] [Abstract][Full Text] [Related]
18. CDT1 facilitates metastasis in prostate cancer and correlates with cell cycle regulation.
Wang C; Che J; Jiang Y; Chen P; Bao G; Li C
Cancer Biomark; 2022; 34(3):459-469. PubMed ID: 35253732
[TBL] [Abstract][Full Text] [Related]
19. Targeting epithelial to mesenchymal transition in prostate cancer by a novel compound, plectranthoic acid, isolated from Ficus microcarpa.
Akhtar N; Syed DN; Lall RK; Mirza B; Mukhtar H
Mol Carcinog; 2018 May; 57(5):653-663. PubMed ID: 29436741
[TBL] [Abstract][Full Text] [Related]
20. RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.
Sangpairoj K; Vivithanaporn P; Apisawetakan S; Chongthammakun S; Sobhon P; Chaithirayanon K
Cell Mol Neurobiol; 2017 Oct; 37(7):1243-1255. PubMed ID: 28012022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]